429
Views
99
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics, Metabolism, and Toxicology of Dichloroacetate

, , , &
Pages 499-539 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Monica J Killen, Susan Giorgi-Coll, Adel Helmy, Peter JA Hutchinson & Keri LH Carpenter. (2019) Metabolism and inflammation: implications for traumatic brain injury therapeutics. Expert Review of Neurotherapeutics 19:3, pages 227-242.
Read now
Paul J Marangos, Catherine C Turkel, Zofia E Dziewanowska & Anthony W Fox. (1999) Dichloroacetate and cerebral ischaemia therapeutics. Expert Opinion on Investigational Drugs 8:4, pages 373-382.
Read now

Articles from other publishers (96)

Seyed Amirhossein Tabatabaei Dakhili, Amanda A. Greenwell & John R. Ussher. (2023) Pyruvate Dehydrogenase Complex and Glucose Oxidation as a Therapeutic Target in Diabetic Heart Disease. Journal of Lipid and Atherosclerosis 12:1, pages 47.
Crossref
Jiko Raut, Md Majharul Islam, Rinchen D. Sherpa, Biraj Sarkar, Shanti M. Mandal, Subhra P. Hui, Sukhendu Mandal & Prithidipa Sahoo. (2022) Cobalt-conjugated carbon quantum dots for in vivo monitoring of the pyruvate dehydrogenase kinase inhibitor drug dichloroacetic acid. Scientific Reports 12:1.
Crossref
Lajpreet Kaur, Mallika Pathak, Siddhartha Dan, Rahul Singhal, Vinod Kumar & Himanshu Ojha. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors 435 456 .
Agunda Chekhoeva, Sentaro Nakanishi, Yukiharu Sugimura, Mahfuza Toshmatova, Anna Kathrin Assmann, Artur Lichtenberg, Payam Akhyari & Alexander Assmann. (2022) Dichloroacetate inhibits the degeneration of decellularized cardiovascular implants. European Journal of Cardio-Thoracic Surgery 61:1, pages 19-26.
Crossref
Serene Joseph, Mengchen Li, Sicong Zhang, Lloyd Horne, Peter W Stacpoole, Stephanie Eva Wohlgemuth, Arthur S. Edison, Charles E. Wood & Maureen Keller-Wood. (2021) Sodium dichloroacetate stimulates cardiac mitochondrial metabolism and improves cardiac conduction in the ovine fetus during labor. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
Crossref
Anthony Lai, Yasemin Sahbaz, Leigh Ford, Tri-Hung Nguyen, Shadabul Haque, Hywel D. Williams, Hassan Benameur, Peter J. Scammells & Christopher J.H. Porter. (2021) Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulations. International Journal of Pharmaceutics 597, pages 120292.
Crossref
Valentina Lagos-Rodríguez, Laura Martínez-Palma, Soledad Marton, Ernesto Miquel, Ricardo Escobar-Pintos, Adriana Cassina, Natalia Lago & Patricia Cassina. (2020) Mitochondrial bioenergetics, glial reactivity, and pain-related behavior can be restored by dichloroacetate treatment in rodent pain models. Pain 161:12, pages 2786-2797.
Crossref
Alba Martínez-Flórez, Melina Galizzi, Luis Izquierdo, Juan M. Bustamante, Ana Rodriguez, Fernando Rodriguez, Alhelí Rodríguez-Cortés & Jordi Alberola. (2020) Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases. International Journal for Parasitology: Drugs and Drug Resistance 14, pages 17-27.
Crossref
Yo Shinoda, Kohei Aoki, Ayaka Shinkai, Kumi Seki, Tsutomu Takahashi, Yayoi Tsuneoka, Jiro Akimoto & Yasuyuki Fujiwara. (2020) Synergistic effect of dichloroacetate on talaporfin sodium-based photodynamic therapy on U251 human astrocytoma cells. Photodiagnosis and Photodynamic Therapy 31, pages 101850.
Crossref
Donatas Stakišaitis, Milda Juknevičienė, Eligija Damanskienė, Angelija Valančiūtė, Ingrida Balnytė & Marta Maria Alonso. (2019) The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo. Cancers 11:8, pages 1210.
Crossref
A. Hartwig. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety 641 664 .
Jūratė Stanevičiūtė, Milda Juknevičienė, Ingrida Balnytė, Angelija Valančiūtė, Vaiva Lesauskaitė, Julija Fadejeva, Rimantas Stakauskas & Donatas Stakišaitis. (2019) Gender-Related Effect of Sodium Dichloroacetate on the Number of Hassall’s Corpuscles and RNA NKCC1 Expression in Rat Thymus. BioMed Research International 2019, pages 1-11.
Crossref
Antonio Lopalco, Alessandra Curci, Angela Lopedota, Annalisa Cutrignelli, Valentino Laquintana, Massimo Franco & Nunzio Denora. (2019) Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate. European Journal of Pharmaceutical Sciences 127, pages 339-350.
Crossref
Jūratė Stanevičiūtė, Milda Juknevičienė, Jolita Palubinskienė, Ingrida Balnytė, Angelija Valančiūtė, Rūta Vosyliūtė, Kęstutis Sužiedėlis, Vaiva Lesauskaitė & Donatas Stakišaitis. (2018) Sodium Dichloroacetate Pharmacological Effect as Related to Na–K–2Cl Cotransporter Inhibition in Rats. Dose-Response 16:4, pages 155932581881152.
Crossref
Maria Buchsteiner, Lake‐Ee Quek, Peter Gray & Lars K. Nielsen. (2018) Improving culture performance and antibody production in CHO cell culture processes by reducing the Warburg effect. Biotechnology and Bioengineering 115:9, pages 2315-2327.
Crossref
Stephan C. Jahn, Marci G. Smeltz, Zhiwei Hu, Laura Rowland-Faux, Guo Zhong, Ryan J. Lorenzo, Katherine V. Cisneros, Peter W. Stacpoole & Margaret O. James. (2018) Regulation of dichloroacetate biotransformation in rat liver and extrahepatic tissues by GSTZ1 expression and chloride concentration. Biochemical Pharmacology 152, pages 236-243.
Crossref
Paola Mirra, Cecilia Nigro, Immacolata Prevenzano, Alessia Leone, Gregory Alexander Raciti, Pietro Formisano, Francesco Beguinot & Claudia Miele. (2018) The Destiny of Glucose from a MicroRNA Perspective. Frontiers in Endocrinology 9.
Crossref
Naveen Mangal, Margaret O. James, Peter W. Stacpoole & Stephan Schmidt. (2018) Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children. The Journal of Clinical Pharmacology 58:2, pages 212-220.
Crossref
Cristina M. Villanueva, Esther Gracia-Lavedan, Jordi Julvez, Loreto Santa-Marina, Nerea Lertxundi, Jesús Ibarluzea, Sabrina Llop, Ferran Ballester, Ana Fernández-Somoano, Adonina Tardón, Martine Vrijheid, Mònica Guxens & Jordi Sunyer. (2018) Drinking water disinfection by-products during pregnancy and child neuropsychological development in the INMA Spanish cohort study. Environment International 110, pages 113-122.
Crossref
. 2017. Computational Chemistry Methodology in Structural Biology and Materials Sciences. Computational Chemistry Methodology in Structural Biology and Materials Sciences 97 130 .
Amira El Arem, Emna Behija Saafi, Lamia Lahouar, Amira Thouri, Fatma Ghrairi & Lotfi Achour. (2017) Date palm fruit extract attenuated oxidative stress induced by two haloacetic acids in Wistar rats. Mediterranean Journal of Nutrition and Metabolism 10:2, pages 141-152.
Crossref
Yu Jiang, Gary Milavetz, Margaret O. James & Guohua An. (2017) A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats. Journal of Pharmaceutical Sciences 106:5, pages 1396-1404.
Crossref
Margaret O. James, Stephan C. Jahn, Guo Zhong, Marci G. Smeltz, Zhiwei Hu & Peter W. Stacpoole. (2017) Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. Pharmacology & Therapeutics 170, pages 166-180.
Crossref
Jurate Stanevičiūtė, Daiva Urbonienė, Angelija Valančiūtė, Ingrida Balnytė, Astra Vitkauskienė, Brigita Grigalevičienė & Donatas Stakišaitis. (2016) The effect of dichloroacetate on male rat thymus and on thymocyte cell cycle. International Journal of Immunopathology and Pharmacology 29:4, pages 818-822.
Crossref
Mithilesh Kumar Jha, Md Habibur Rahman, Dong Ho Park, Hyun Kook, In-Kyu Lee, Won-Ha Lee & Kyoungho Suk. (2016) Pyruvate dehydrogenase kinase 2 and 4 gene deficiency attenuates nociceptive behaviors in a mouse model of acute inflammatory pain. Journal of Neuroscience Research 94:9, pages 837-849.
Crossref
Margaret O James & Peter W Stacpoole. (2016) Pharmacogenetic considerations with dichloroacetate dosing. Pharmacogenomics 17:7, pages 743-753.
Crossref
Md Habibur Rahman, Mithilesh Kumar Jha, Jong-Heon Kim, Youngpyo Nam, Maan Gee Lee, Younghoon Go, Robert A. Harris, Dong Ho Park, Hyun Kook, In-Kyu Lee & Kyoungho Suk. (2016) Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy. Journal of Biological Chemistry 291:11, pages 6011-6025.
Crossref
Richard Hill, Samantha A. Murray, Zaynah Maherally, Samantha C. Higgins & Geoffrey J. Pilkington. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers 107 144 .
Mithilesh Kumar Jha, Gyun Jee Song, Maan Gee Lee, Nam Ho Jeoung, Younghoon Go, Robert A. Harris, Dong Ho Park, Hyun Kook, In-Kyu Lee & Kyoungho Suk. (2015) Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis. The Journal of Neuroscience 35:42, pages 14353-14369.
Crossref
Rosa Ferriero, Clara Iannuzzi, Giuseppe Manco & Nicola Brunetti-Pierri. (2015) Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate. Journal of Inherited Metabolic Disease 38:5, pages 895-904.
Crossref
Laura Di Magno, Sonia Coni, Lucia Di Marcotullio & Gianluca Canettieri. (2015) Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1856:1, pages 62-72.
Crossref
Quincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, Larissa J. Vos, John R. Mackey, Alexander J. B. McEwan, Peter Venner & Evangelos D. Michelakis. (2015) A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors. Investigational New Drugs 33:3, pages 603-610.
Crossref
Albert L. Shroads, Bonnie S. Coats, Taimour Langaee, Jonathan J. Shuster & Peter W. Stacpoole. (2015) Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans. Drug Metabolism and Personalized Therapy 30:1.
Crossref
Alexis Valauri-Orton, Frizzi Bschorer & Karen K. Bernd. (2015) Dichloroacetate Decreases Cell Health and Activates Oxidative Stress Defense Pathways in Rat Alveolar Type II Pneumocytes. BioMed Research International 2015, pages 1-6.
Crossref
Shyam Kankotia & Peter W. Stacpoole. (2014) Dichloroacetate and cancer: New home for an orphan drug?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 617-629.
Crossref
Cristina R. Bosoi, Claudia Zwingmann, Helen Marin, Christian Parent-Robitaille, Jimmy Huynh, Mélanie Tremblay & Christopher F. Rose. (2014) Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. Journal of Hepatology 60:3, pages 554-560.
Crossref
Hanford K. Yau & Peter W. Stacpoole. 2021. Encyclopedia of Malaria. Encyclopedia of Malaria 1 20 .
Mette Hauge Lauritzen, Christoffer Laustsen, Sadia Asghar Butt, Peter Magnusson, Lise Vejby Søgaard, Jan Henrik Ardenkjaer-Larsen & Per Åkeson. (2013) Enhancing the [ 13 C]bicarbonate signal in cardiac hyperpolarized [1- 13 C]pyruvate MRS studies by infusion of glucose, insulin and potassium . NMR in Biomedicine 26:11, pages 1496-1500.
Crossref
Jan Gruber, Sheng Fong, Ce-Belle Chen, Sialee Yoong, Giorgia Pastorin, Sebastian Schaffer, Irwin Cheah & Barry Halliwell. (2013) Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnology Advances 31:5, pages 563-592.
Crossref
Philip G. Board & Deepthi Menon. (2013) Glutathione transferases, regulators of cellular metabolism and physiology. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:5, pages 3267-3288.
Crossref
Y-C Shen, D-L Ou, C Hsu, K-L Lin, C-Y Chang, C-Y Lin, S-H Liu & A-L Cheng. (2012) Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. British Journal of Cancer 108:1, pages 72-81.
Crossref
Joanne E. Mallinson, Dumitru Constantin‐Teodosiu, Philip D. Glaves, Elizabeth A. Martin, Wendy J. Davies, F. Russell Westwood, James E. Sidaway & Paul L. Greenhaff. (2012) Pharmacological activation of the pyruvate dehydrogenase complex reduces statin‐mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. The Journal of Physiology 590:24, pages 6389-6402.
Crossref
Tianwen Li, Yongchong Yang, Changmei Cheng, Amit K. Tiwari, Kamlesh Sodani, Yufen Zhao, Ioana Abraham & Zhe-Sheng Chen. (2012) Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agents. Bioorganic & Medicinal Chemistry Letters 22:23, pages 7268-7271.
Crossref
Albert L. Shroads, Taimour Langaee, Bonnie S. Coats, Tracie L. Kurtz, John R. Bullock, David Weithorn, Yan Gong, David A. Wagner, David A. Ostrov, Julie A. Johnson & Peter W. Stacpoole. (2013) Human Polymorphisms in the Glutathione Transferase Zeta 1/Maleylacetoacetate Isomerase Gene Influence the Toxicokinetics of Dichloroacetate. The Journal of Clinical Pharmacology 52:6, pages 837-849.
Crossref
John R. Ussher, Wei Wang, Manoj Gandhi, Wendy Keung, Victor Samokhvalov, Tatsujiro Oka, Cory S. Wagg, Jagdip S. Jaswal, Robert A. Harris, Alexander S. Clanachan, Jason R.B. Dyck & Gary D. Lopaschuk. (2012) Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovascular Research 94:2, pages 359-369.
Crossref
Serena Vella, Matteo Conti, Roberta Tasso, Ranieri Cancedda & Aldo Pagano. (2011) Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. International Journal of Cancer 130:7, pages 1484-1493.
Crossref
TATSUAKI ISHIGURO, MIYU ISHIGURO, RYUMEI ISHIGURO & SAYURI IWAI. (2012) Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumors. Oncology Letters 3:3, pages 726-728.
Crossref
. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety 1 136 .
. 2002. The MAK-Collection for Occupational Health and Safety. The MAK-Collection for Occupational Health and Safety 1 318 .
E Babu, S Ramachandran, V CoothanKandaswamy, S Elangovan, P D Prasad, V Ganapathy & M Thangaraju. (2011) Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate. Oncogene 30:38, pages 4026-4037.
Crossref
Peter W. Stacpoole. (2011) Why are there no proven therapies for genetic mitochondrial diseases?. Mitochondrion 11:5, pages 679-685.
Crossref
Ioanna Papandreou, Tereza Goliasova & Nicholas C. Denko. (2010) Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?. International Journal of Cancer 128:5, pages 1001-1008.
Crossref
Peter W. Stacpoole. (2011) The Dichloroacetate Dilemma: Environmental Hazard versus Therapeutic Goldmine—Both or Neither?. Environmental Health Perspectives 119:2, pages 155-158.
Crossref
Wenjun Li, Margaret O. James, Sarah C. McKenzie, Nigel A. Calcutt, Chen Liu & Peter W. Stacpoole. (2011) Mitochondrion as a Novel Site of Dichloroacetate Biotransformation by Glutathione Transferase ζ1. Journal of Pharmacology and Experimental Therapeutics 336:1, pages 87-94.
Crossref
Jing Nie, Debra C. DuBois, William J. Jusko & Richard R. Almon. (2011) Mechanistic population modeling of diabetes disease progression in Goto-Kakizaki rat muscle. Biopharmaceutics & Drug Disposition 32:1, pages 50-63.
Crossref
JILL EDITH KISLER, ROGER GRAHAM WHITTAKER & ROBERT MCFARLAND. (2010) Mitochondrial diseases in childhood: a clinical approach to investigation and management. Developmental Medicine & Child Neurology 52:5, pages 422-433.
Crossref
Misha Angrist. (2012) Only Connect. Molecular Diagnosis & Therapy 14:2, pages 67-72.
Crossref
Daniel J. M. Fernández-Ayala, Shanjun Chen, Esko Kemppainen, Kevin M. C. O'Dell & Howard T. Jacobs. (2010) Gene Expression in a Drosophila Model of Mitochondrial Disease. PLoS ONE 5:1, pages e8549.
Crossref
Byounghoon HwangNam Ho JeoungRobert A. Harris. (2009) Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet. Biochemical Journal 423:2, pages 243-252.
Crossref
Peter W. Stacpoole, Tracie L. Kurtz, Zongchao Han & Taimour Langaee. (2008) Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Advanced Drug Delivery Reviews 60:13-14, pages 1478-1487.
Crossref
Natalia Felitsyn, Colin McLeod, Albert L. Shroads, Peter W. Stacpoole & Lucia Notterpek. (2008) The heme precursor delta-aminolevulinate blocks peripheral myelin formation. Journal of Neurochemistry.
Crossref
Peter W. Stacpoole, Lesa R. Gilbert, Richard E. Neiberger, Paul R. Carney, Edward Valenstein, Douglas W. Theriaque & Jonathan J. Shuster. (2008) Evaluation of Long-term Treatment of Children With Congenital Lactic Acidosis With Dichloroacetate. Pediatrics 121:5, pages e1223-e1228.
Crossref
N. H. Jeoung & R. A. Harris. (2008) Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. AJP: Endocrinology and Metabolism 295:1, pages E46-E54.
Crossref
Albert L. Shroads, Xu Guo, Vaishali Dixit, Hui-Ping Liu, Margaret O. James & Peter W. Stacpoole. (2008) Age-Dependent Kinetics and Metabolism of Dichloroacetate: Possible Relevance to Toxicity. Journal of Pharmacology and Experimental Therapeutics 324:3, pages 1163-1171.
Crossref
Ting Li, Irv Schultz, Deborah A. Keys, Jerry L. Campbell & Jeffrey W. Fisher. (2008) Quantitative evaluation of dichloroacetic acid kinetics in human—a physiologically based pharmacokinetic modeling investigation. Toxicology 245:1-2, pages 35-48.
Crossref
Rachelle R. Landgraf, Timothy J. Garrett, Nigel A. Calcutt, Peter W. Stacpoole & Richard A. Yost. (2007) MALDI-Linear Ion Trap Microprobe MS/MS Studies of the Effects of Dichloroacetate on Lipid Content of Nerve Tissue. Analytical Chemistry 79:21, pages 8170-8175.
Crossref
Natalia Felitsyn, Peter W. Stacpoole & Lucia Notterpek. (2007) Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect. Journal of Neurochemistry 100:2, pages 429-436.
Crossref
Minghong Jia, Bonnie Coats, Monisha Chadha, Barbara Frentzen, Javier Perez-Rodriguez, Paul A. Chadik, Richard A. Yost, George N. Henderson & Peter W. Stacpoole. (2006) Human Kinetics of Orally and Intravenously Administered Low-Dose 1,2- 13 C-Dichloroacetate . The Journal of Clinical Pharmacology 46:12, pages 1449-1459.
Crossref
Irvin R. Schultz & Robert E. Shangraw. (2006) Effect of Short-Term Drinking Water Exposure to Dichloroacetate on its Pharmacokinetics and Oral Bioavailability in Human Volunteers: A Stable Isotope Study. Toxicological Sciences 92:1, pages 42-50.
Crossref
Kristen Berendzen, Douglas W. Theriaque, Jonathan Shuster & Peter W. Stacpoole. (2006) Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. Mitochondrion 6:3, pages 126-135.
Crossref
Melissa D. Zolodz, Minghong Jia, Huiping Liu, George N. Henderson & Peter W. Stacpoole. (2006) A GC?MS/MS method for the quantitative analysis of low levels of the tyrosine metabolites maleylacetone, succinylacetone, and the tyrosine metabolism inhibitor dichloroacetate in biological fluids and tissues. Journal of Chromatography B 837:1-2, pages 125-132.
Crossref
Peter W. Stacpoole, Douglas S. Kerr, Carie Barnes, S. Terri Bunch, Paul R. Carney, Eileen M. Fennell, Natalia M. Felitsyn, Robin L. Gilmore, Melvin Greer, George N. Henderson, Alan D. Hutson, Richard E. Neiberger, Ralph G. O'Brien, Leigh Ann Perkins, Ronald G. Quisling, Albert L. Shroads, Jonathan J. Shuster, Janet H. Silverstein, Douglas W. Theriaque & Edward Valenstein. (2006) Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children. Pediatrics 117:5, pages 1519-1531.
Crossref
Yu-Yan Fang, Uliana Kashkarov, M.W. Anders & Philip G. Board. (2006) Polymorphisms in the human glutathione transferase zeta promoter. Pharmacogenetics and Genomics 16:5, pages 307-313.
Crossref
Chantale Langlois, Rossana Jorquera, Milton Finegold, Albert L. Shroads, Peter W. Stacpoole & Robert M. Tanguay. (2006) Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1. Biochemical Pharmacology 71:11, pages 1648-1661.
Crossref
P. KaufmannK. EngelstadY. WeiS. JhungM. C. SanoD. C. ShunguW. S. MillarX. HongC. L. GoochX. MaoJ. M. PascualM. HiranoP. W. StacpooleS. DiMauroD. C. De Vivo. (2006) Dichloroacetate causes toxic neuropathy in MELAS. Neurology 66:3, pages 324-330.
Crossref
Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James & Peter W. Stacpoole. (2006) INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S -TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL . Drug Metabolism and Disposition 34:1, pages 36-42.
Crossref
Thorsten R. Knoechel, Alec D. Tucker, Colin M. Robinson, Chris Phillips, Wendy Taylor, Peter J. Bungay, Shane A. Kasten, Thomas E. Roche & David G. Brown. (2005) Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands , . Biochemistry 45:2, pages 402-415.
Crossref
R.M. MayersB. LeightonE. Kilgour. (2005) PDH kinase inhibitors: a novel therapy for Type II diabetes?. Biochemical Society Transactions 33:2, pages 367-370.
Crossref
T. Planche, A. Dzeing, E. Ngou-Milama, M. Kombila & P. W. Stacpoole. 2005. Malaria: Drugs, Disease and Post-genomic Biology. Malaria: Drugs, Disease and Post-genomic Biology 105 136 .
Wayne B. Anderson, Philip G. Board & M. W. Anders. (2004) Glutathione Transferase Zeta-Catalyzed Bioactivation of Dichloroacetic Acid:  Reaction of Glyoxylate with Amino Acid Nucleophiles. Chemical Research in Toxicology 17:5, pages 650-662.
Crossref
Chandramohan V Ammini, Jose Fernandez-Canon, Albert L Shroads, Rachel Cornett, Jang Cheung, Margaret O James, George N Henderson, Markus Grompe & Peter W Stacpoole. (2003) Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents. Biochemical Pharmacology 66:10, pages 2029-2038.
Crossref
Minghong Jia, Wells W. Wu, Richard A. Yost, Paul A. Chadik, Peter W. Stacpoole & George N. Henderson. (2003) Simultaneous Determination of Trace Levels of Nine Haloacetic Acids in Biological Samples as Their Pentafluorobenzyl Derivatives by Gas Chromatography/Tandem Mass Spectrometry in Electron Capture Negative Ion Chemical Ionization Mode. Analytical Chemistry 75:16, pages 4065-4080.
Crossref
Ted M. Burns, Monique M. Ryan, Basil Darras & H. Royden JonesJrJr. (2003) Current Therapeutic Strategies for Patients With Polyneuropathies Secondary to Inherited Metabolic Disorders. Mayo Clinic Proceedings 78:7, pages 858-868.
Crossref
Peter W. Stacpoole, Nelamangala V. Nagaraja & Alan D. Hutson. (2003) Efficacy of Dichloroacetate as a Lactate-Lowering Drug. The Journal of Clinical Pharmacology 43:7, pages 683-691.
Crossref
Tsiri Agbenyega, Tim Planche, George Bedu-Addo, Daniel Ansong, Alex Owusu-Ofori, Venkatesh A. Bhattaram, Nelamangala V. Nagaraja, Albert L. Shroads, George N. Henderson, Alan D. Hutson, Hartmut Derendorf, Sanjeev Krishna & Peter W. Stacpoole. (2003) Population Kinetics, Efficacy, and Safety of Dichloroacetate for Lactic Acidosis Due to Severe Malaria in Children. The Journal of Clinical Pharmacology 43:4, pages 386-396.
Crossref
Sheau-Fung Thai, James W Allen, Anthony B DeAngelo, Michael H George & James C Fuscoe. (2003) Altered gene expression in mouse livers after dichloroacetic acid exposure. Mutation Research/Reviews in Mutation Research 543:2, pages 167-180.
Crossref
Wayne B. Anderson, Daniel C. Liebler, Philip G. Board & M. W. Anders. (2002) Mass Spectral Characterization of Dichloroacetic Acid-Modified Human Glutathione Transferase Zeta. Chemical Research in Toxicology 15:11, pages 1387-1397.
Crossref
Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board & M. W. Anders. (2002) Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues. Drug Metabolism and Disposition 30:6, pages 616-625.
Crossref
Hoffman B. M. Lantum, Daniel C. Liebler, Philip G. Board & M. W. Anders. (2002) Alkylation and Inactivation of Human Glutathione Transferase Zeta (hGSTZ1-1) by Maleylacetone and Fumarylacetone. Chemical Research in Toxicology 15:5, pages 707-716.
Crossref
L.T. Haber, A. Maier, P.R. Gentry, H.J. Clewell & M.L. Dourson. (2002) Genetic Polymorphisms in Assessing Interindividual Variability in Delivered Dose. Regulatory Toxicology and Pharmacology 35:2, pages 177-197.
Crossref
G. A. Schmidt. 2002. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. 681 693 .
Masayuki TaniguchiCraig Wilson, Charlene A. HunterDaniel J. Pehowich, Alexander S. ClanachanGary D. Lopaschuk. (2001) Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. American Journal of Physiology-Heart and Circulatory Physiology 280:4, pages H1762-H1769.
Crossref
Huey-Fen Tzeng, Anneke C. Blackburn, Philip G. Board & M. W. Anders. (2000) Polymorphism- and Species-Dependent Inactivation of Glutathione Transferase Zeta by Dichloroacetate. Chemical Research in Toxicology 13:4, pages 231-236.
Crossref
Wayne B. Anderson, Philip G. Board, Bryan Gargano & M. W. Anders. (1999) Inactivation of Glutathione Transferase Zeta by Dichloroacetic Acid and Other Fluorine-Lacking α-Haloalkanoic Acids. Chemical Research in Toxicology 12:12, pages 1144-1149.
Crossref
Rachel Cornett, Margaret O. James, George N. Henderson, Jang Cheung, Albert L. Shroads & Peter W. Stacpoole. (1999) Inhibition of Glutathione S-Transferase ? and Tyrosine Metabolism by Dichloroacetate: A Potential Unifying Mechanism for Its Altered Biotransformation and Toxicity. Biochemical and Biophysical Research Communications 262:3, pages 752-756.
Crossref
P W Stacpoole, G N Henderson, Z Yan & M O James. (1998) Clinical pharmacology and toxicology of dichloroacetate.. Environmental Health Perspectives 106:suppl 4, pages 989-994.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.